Mycoplasma Testing Market Research Report - Forecast till 2027

Mycoplasma Testing Market Research Report: By Product (Kits & Reagents, Instruments, Services), Technique (DNA, PCR, ELISA, Direct, Indirect Assay), Application (cell line testing, virus testing), End user (CRO, Cell banks) - Forecast till 2027

ID: MRFR/LS/5312-HCR | February 2021 | Region: Global | 100 pages

Mycoplasma Testing Market Scenario:


Mycoplasma Testing Market is expected to grow significantly over the forecast period. It is anticipated that the mycoplasma testing market held a market value of USD 514 million in 2017 and is projected to grow at a CAGR of 11.6% over the forecast period. Mycoplasma testing used to detect contamination in given biologic sample.


The factors such as Increasing R&D expense and new product launches are expected to propel the growth of the mycoplasma testing market. However, available of alternative traditional method hamper the mycoplasma testing market growth over the forecast period.


Key players:


Charles River Laboratories, Inc., Merck KGaA, Lonza Group Ltd, Roche Diagnostics, SGS S.A., American Type Culture Collection, Invivogen, Wuxi Apptec, Thermo Fisher Scientific Inc., Promocell GmbH are some of the key players in the mycoplasma testing market. 


Market Segmentation:


The mycoplasma testing market has been segmented into product, Technique, and application.


Based on product, market segmented into kits & reagents, instruments, and services. The kits & reagents segment is expected to account for the largest share segment of the market in 2017.


Based on Technique, market segmented into DNA Stain, Enzyme-based, PCR, ELISA, Direct Assay, Indirect Assay, Others.


Based on application, market segmented into cell line and cell therapy testing, virus testing, row material testing, lot release testing, and others.


Based on end user, market segmented into pharmaceutical and biological manufacturing, contract research organizations, cell banks, and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The mycoplasma testing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European mycoplasma testing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The mycoplasma testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The mycoplasma testing market in the Middle East & Africa has been segmented into the Middle East and Africa.


Global Mycoplasma Testing Market Share (%), by Region, 2017


Source: Annual Reports and Sec filings


Regional Market Summary


Geographically, the Americas is anticipated to dominate the mycoplasma testing market owing to a well-established player and increasing R&D expenses.


Europe is expected to hold the second largest position in the mycoplasma testing market. The market growth in this region is attributed to the growth in pharmaceutical and medical device industry.


The mycoplasma testing market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increasing adoption of these products.


The Middle East & Africa has the least share of the market.


By Product



  • Kits & Reagents

  • Instruments

  • Services


By Technique



  • DNA Stain

  • Enzyme-based

  • PCR

  • ELISA

  • Direct Assay

  • Indirect Assay

  • Others


By Application



  • Cell Line and Cell Therapy Testing

  • Virus Testing

  • Row Material Testing

  • Lot Release Testing

  • Others


By End User



  • Pharmaceutical and Biological Manufacturing

  • Contract Research Organizations

  • Cell Banks

  • Others


By Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




The report for Mycoplasma Testing Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.


Intended Audience



  • Mycoplasma testing products Manufacturers and vendors

  • Mycoplasma testing service providers

  • Pharmaceutical and Biotech companies

  • Contract research organization

  • Various research and consulting firms



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2017: USD 514 Million
  • 2027: Significant Value
  •   CAGR   11.6% (2018-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Product, Technique, and Application
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Charles River Laboratories, Inc., Merck KGaA, Lonza Group Ltd, Roche Diagnostics, SGS S.A., American Type Culture Collection, Invivogen, Wuxi Apptec, Thermo Fisher Scientific Inc., Promocell GmbH
      Key Market Opportunities   Increasing R&D expense and new product launches
      Key Market Drivers   Growing concerns over cell culture contamination


    Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The mycoplasma testing market is projected to grow at an 11.6% CAGR between 2018-2023.

    The Americas is projected to command the largest share in the mycoplasma testing market.

    It is widely used in lot release testing, virus testing, and others.

    New product launches and increasing R&D expenditure is adding market growth.

    Availability of alternatives may limit market growth.

    Table of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    Chapter 6. Global Mycoplasma Testing Market, by Product

    6.1 Introduction

    6.2 Kits & Reagents

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Instruments

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Services

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Mycoplasma Testing Market, by Technology

    7.1 Introduction

    7.2 DNA Stain

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Enzyme-based

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 PCR

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.5 ELISA

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.6 Direct Assay

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.7 Direct Assay

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.8 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Mycoplasma Testing Market, by Application

    8.1 Introduction

    8.2 Cell Line and Cell Therapy Testing

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Virus Testing

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Row Material Testing

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.5 Lot Material Testing

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.6 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Mycoplasma Testing Market, by End User

    9.1 Introduction

    9.2 Pharmaceutical and Biological Manufacturing

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.3 Contract Research Organizations

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.4 Cell Banks

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.5 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 10. Global Mycoplasma Testing Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 US

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 UK

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia-Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 South Korea

    10.4.6 Rest of Asia-Pacific

    10.5 Middle East & Africa

    10.5.1 Middle East

    10.5.2 Africa

    Chapter 11. Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    Chapter 12. Company Profiles

    12.1 Charles River Laboratories, Inc.

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials Overview

    12.1.4 Key Developments

    12.1.5 SWOT Analysis

    12.2 Merck KGaA

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Lonza Group Ltd

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Roche Diagnostics

    12.4.1 Company Overview

    12.4.2 Product Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 SGS S.A.

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.5.5 SWOT Analysis

    12.6 American Type Culture Collection

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.6.5 SWOT Analysis

    12.7 Invivogen

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financial Overview

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Wuxi Apptec

    12.8.1 Overview

    12.8.2 Product Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Promocell GmbH

    12.9.1 Overview

    12.9.2 Product Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.10 Thermo Fisher Scientific Inc.

    12.10.1 Overview

    12.10.2 Product Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12.11 Others

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Predictions for the Mycoplasma Testing Industry

    Chapter 14. Appendix


    LIST OF TABLES

    Table 1 Global Mycoplasma Testing Market Synopsis, 2020-2027

    Table 2 Global Mycoplasma Testing Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Mycoplasma Testing Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

    Table 5 Global Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

    Table 6 Global Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

    Table 7 Global Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

    Table 8 North America: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

    Table 9 North America: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

    Table 10 North America: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

    Table 11 North America: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

    Table 12 US: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

    Table 13 US: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

    Table 14 US: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

    Table 15 US: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

    Table 16 Canada: Mycoplasma Testing Market,by Product, 2020-2027 (USD Million)

    Table 17 Canada: Mycoplasma Testing Market,by Technique, 2020-2027 (USD Million)

    Table 18 Canada: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

    Table 19 Canada: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

    Table 20 South America: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

    Table 21 South America: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

    Table 22 South America: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

    Table 23 South America: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

    Table 24 Europe: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

    Table 25 Europe: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

    Table 26 Europe: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

    Table 27 Europe: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

    Table 28 Western Europe: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

    Table 29 Western Europe: Mycoplasma Testing Market, by Technique, 2020-2027

    (USD Million)

    Table 30 Western Europe: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

    Table 31 Western Europe: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

    Table 32 Eastern Europe: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

    Table 33 Eastern Europe: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

    Table 34 Eastern Europe: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

    Table 35 Eastern Europe: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

    Table 36 Asia-Pacific: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

    Table 37 Asia-Pacific: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

    Table 38 Asia-Pacific: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

    Table 39 Asia-Pacific: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

    Table 40 Middle East & Africa: Mycoplasma Testing Market, by Product, 2020-2027

    (USD Million)

    Table 41 Middle East & Africa: Mycoplasma Testing Market, by Technique, 2020-2027

    (USD Million)

    Table 42 Middle East & Africa: Mycoplasma Testing Market, by Application, 2020–

    2027 (USD Million)

    Table 43 Middle East & Africa: Mycoplasma Testing Market, by End User, 2020–

    2027 (USD Million)


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Mycoplasma Testing Market

    Figure 3 Segmentation Market Dynamics for Global Mycoplasma Testing Market

    Figure 4 Global Mycoplasma Testing Market Share, by Product, 2020

    Figure 5 Global Mycoplasma Testing Market Share, by Technique, 2020

    Figure 6 Global Mycoplasma Testing Market Share, by Application, 2020

    Figure 7 Global Mycoplasma Testing Market Share, by End User, 2020

    Figure 8 Global Mycoplasma Testing Market Share, by Region, 2020

    Figure 9 North America: Mycoplasma Testing Market Share, by Country, 2020

    Figure 10 Europe: Mycoplasma Testing Market Share, by Country, 2020

    Figure 11 Asia-Pacific: Mycoplasma Testing Market Share, by Country, 2020

    Figure 12 Middle East & Africa: Mycoplasma Testing Market Share, by Country, 2020

    Figure 13 Global Mycoplasma Testing Market: Company Share Analysis, 2020 (%)

    Figure 14 Charles River Laboratories, Inc : Key Financials

    Figure 15 Charles River Laboratories, Inc : Segmental Revenue

    Figure 16 Charles River Laboratories, Inc : Geographical Revenue

    Figure 17 Merck KGaA: Key Financials

    Figure 18 Merck KGaA: Segmental Revenue

    Figure 19 Merck KGaA: Geographical Revenue

    Figure 20 Lonza Group Ltd: Key Financials

    Figure 21 Lonza Group Ltd: Segmental Revenue

    Figure 22 Lonza Group Ltd: Geographical Revenue

    Figure 23 Roche Diagnostics: Key Financials

    Figure 24 Roche Diagnostics: Segmental Revenue

    Figure 25 Roche Diagnostics: Geographical Revenue

    Figure 26 SGS S.A.: Key Financials

    Figure 27 SGS S.A.: Segmental Revenue

    Figure 28 SGS S.A.. Geographical Revenue

    Figure 29 American Type Culture Collection: Key Financials

    Figure 30 American Type Culture Collection: Segmental Revenue

    Figure 31 American Type Culture Collection: Geographical Revenue

    Figure 32 Invivogen: Key Financials

    Figure 33 Invivogen: Segmental Revenue

    Figure 34 Invivogen: Geographical Revenue

    Figure 35 Wuxi Apptec: Key Financials

    Figure 36 Wuxi Apptec: Segmental Revenue

    Figure 37 Wuxi Apptec: Geographical Revenue

    Figure 38 Thermo Fisher Scientific Inc: Key Financials

    Figure 39 Thermo Fisher Scientific Inc: Segmental Revenue

    Figure 40 Thermo Fisher Scientific Inc: Geographical Revenue

    Figure 41 Promocell GmbH: Key Financials

    Figure 42 Promocell GmbH: Segmental Revenue

    Figure 43 Promocell GmbH: Geographical Revenue